Performance of the SF-36, SF-12, and RAND-36 Summary Scales in a Multiple Sclerosis Population

Background.Multiple sclerosis (MS) patients accumulate both physical and mental health problems along with disease progression. Valid and sensitive outcome measures are important to measure disease effects and the effect of treatment. Objective.The objective of this study was to test the performance of the physical and mental summary scales of SF-36, SF-12, and RAND-36. Methods.The scales were evaluated by comparing the scores of a cohort of 194 MS patients with general population data and using the Expanded Disability Status Scale (EDSS) and the Incapacity Status Scale–mental as criterion variables for physical functioning and mental health. Results.All 3 physical summary scales were markedly reduced and correlated highly with the EDSS. The SF-36 mental summary score was only slightly reduced among MS patients (0.2 SD) compared with the general population, despite significantly reduced scores on all 4 health scales being most related to mental health and despite a high prevalence of mental health problems. This results from the poor physical functioning (mean scale score, 2.3 SD below the general population) and the orthogonal factor rotation used to derive independent measures of physical and mental health. Similar results were found for the SF-12. The nonorthogonal RAND-36 physical and mental summary scores were both markedly reduced. This is more compatible with the disease progression in MS and the results of the other measures of physical and mental health used in the study. Conclusions.The SF-36 and SF-12 mental health summary scales appear to overestimate mental health in people with MS.

[1]  M. Hjermstad,et al.  Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. , 1998, Journal of clinical epidemiology.

[2]  D. Revicki,et al.  SF-36 summary scores: are physical and mental health truly distinct? , 1998, Medical care.

[3]  R. Hays,et al.  Health Related Quality of Life in HIV Disease , 1995 .

[4]  T. Riise,et al.  Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models. , 1988, Journal of clinical epidemiology.

[5]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[6]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[7]  J. Kurtzke.  A PROPOSAL FOR A UNIFORM MINIMAL RECORD OF DISABILITY IN MULTIPLE SCLEROSIS , 1981 .

[8]  W H Rogers,et al.  Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. , 1995, Medical care.

[9]  M. Reznikoff,et al.  Depression in multiple sclerosis as a function of length and severity of illness, age, remissions, and perceived social support. , 1984, Journal of clinical psychology.

[10]  T. Riise,et al.  Type I interferons and the quality of life of multiple sclerosis patients. Results from a clinical trial on interferon alfa-2a , 1999, Multiple sclerosis.

[11]  J. Ware,et al.  Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. , 1998, Journal of clinical epidemiology.

[12]  W. Hopman,et al.  Measurement of Health-Related Quality of Life in Multiple Sclerosis Patients , 1996, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[13]  J. Ware,et al.  What information do consumers want and how will they use it? , 1995, Medical care.

[14]  C. Sherbourne,et al.  Four-year cross-lagged associations between physical and mental health in the Medical Outcomes Study. , 1994, Journal of consulting and clinical psychology.

[15]  T. Riise,et al.  Quality of life as a predictor for change in disability in MS , 2000, Neurology.

[16]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[17]  K. Hyllested,et al.  Survival of patients with multiple sclerosis in Denmark , 1994, Neurology.

[18]  J. Kurtzke.  Disability Rating Scales in Multiple Sclerosis , 1984, Annals of the New York Academy of Sciences.

[19]  A. Strong,et al.  Extracellular potassium activity, evoked potential and rCBF during experimental cerebral ischaemia in the baboon. , 1981, Acta neurologica Scandinavica. Supplementum.

[20]  Stephen M. Rao,et al.  Development of a multiple sclerosis functional composite as a clinical trial outcome measure. , 1999, Brain : a journal of neurology.

[21]  H. McFarland,et al.  Outcomes assessment in multiple sclerosis clinical trials: a critical analysis , 1995, Multiple sclerosis.

[22]  John E. Ware,et al.  SF-36 physical and mental health summary scales : a user's manual , 1994 .

[23]  J. E. Brazier,et al.  Validating the SF-36 health survey questionnaire: new outcome measure for primary care. , 1992, BMJ.

[24]  T. Riise,et al.  Quality of life in multiple sclerosis , 1999, Neurology.